Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that researchers presented data from clinical trials demonstrating the clinical benefits of chronic Soliris ® (eculizumab) treatment in patients...
New Alnylam Pre-clinical Results On ALN-CC5, An RNAi Therapeutic Targeting Complement Component C5 For The Treatment Of Complement-Mediated Diseases, Demonstrate Up To 98% Serum C5 Knockdown And Up To 94% Inhibition Of Hemolytic Activity In Non-Human Primates
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-CC5, a subcutaneously administered RNAi therapeutic targeting ...
King Abdulaziz City for Science and Technology Partners with Life Technologies to Analyze 100,000 Human Genomes to Identify the Causes of Disease in the Population of the Kingdom of Saudi Arabia and the Arab World
Nuverra Environmental Solutions (NYSE:NES), (“Nuverra” or the “Company”), a leading provider of full-cycle environmental solutions to energy and industrial end-markets, responded to the District Court...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced results of a Phase 2 study (Study 101-09) evaluating idelalisib, an investigational oral inhibitor of PI3K delta, for the treatment of patients with indolent ...
Leading Australian market advisory firm, capioIT has announced the release of the 2013 Australian Infrastructure Services Capture Share report. This report evaluates the key strengths and weaknesses of 16 leading Australian Infrastructure Services providers.
Do Your Research And Take Advantage Of Both Online And In-store Deals For The Most Sought After Gifts This Season - Wearable Tech, Tablets And Gaming Systems - And Consider Protecting These Expensive Items With Extended Protection Plans.
It is hard to keep sane and stay within budget during the annual holiday season.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV